NCT03009656

Brief Summary

The emergency setting for acute neurological conditions, such as stroke, is peculiar due to time pressure and limited resources for further diagnostics. Clinical skills are essential for swift and accurate bedside diagnosis and thus are the basis for early and correct treatment. This is especially evident in the context of computed tomography being the standard neuroimaging method world-wide with its limitations for detecting smaller infarcts, strokes in the posterior fossa and reduced sensitivity for stroke mimics, such as epileptic seizures or migraine aura. To date, the accuracy of clinical bedside diagnosis of stroke by neurologists verified by magnetic resonance imaging (MRI) in the emergency setting has not been studied in detail. In order to improve clinical diagnosing and future treatment it is essential to quantify the accuracy of clinical diagnosis of stroke in the emergency setting ("how good are neurologists?") and to assesses whether there are any differences between experienced staff neurologists and junior physicians.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 2, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 4, 2017

Completed
6 days until next milestone

Study Start

First participant enrolled

January 10, 2017

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

July 8, 2019

Status Verified

July 1, 2019

Enrollment Period

4 years

First QC Date

January 2, 2017

Last Update Submit

July 4, 2019

Conditions

Keywords

StrokeEmergencyFocal Neurological DeficitsDiagnostic

Outcome Measures

Primary Outcomes (1)

  • Proportion of correct initial diagnoses by emergency physicians in patients with focal clinical neurological deficits

    Primary endpoint is the proportion of correct initial diagnoses by emergency physicians in patients with focal clinical neurological deficits, calculated by comparing the initial assessment with the final diagnosis at discharge. If the initial assessment was correct, the diagnosis of the emergency physician will be rated as correct (correct answer = Ac), if it was incorrect, it will be rated as incorrect (incorrect answer = Ai). The proportion of accurate initial diagnoses will be calculated as: Ac / (Ac + Ai)

    7 days +/- 7 days

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with focal neurological deficits in the Emergency Room of Inselspital Bern.

You may qualify if:

  • Age ≥ 18 years.
  • Non-refusal of "general consent"
  • Patients with focal clinical neurological deficits with symptom onset of \< 6 hours or wake-up strokes.

You may not qualify if:

  • Interval from symptom onset to clinical examination of \> 6 hours.
  • Patients who do not have focal clinical neurological deficit at examination will not be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bern University Hospital - Inselspital

Bern, Canton of Bern, 3010, Switzerland

RECRUITING

MeSH Terms

Conditions

StrokeHemorrhagic StrokeThrombotic StrokeEmergenciesDisease

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesIschemic StrokeDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Christoph Schankin, PD Dr. med.

    Insel Gruppe AG, University Hospital Bern

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christoph Schankin, PD Dr. med.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 2, 2017

First Posted

January 4, 2017

Study Start

January 10, 2017

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

July 8, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations